stockrowAstraZeneca PLC
AZN Healthcare Drug Manufacturers General
AstraZeneca PLC’s revenue for fiscal 2025 (year ended December 2025) was $58.7 billion, up 8.63% from fiscal 2024.
- Revenue
- +6.70%
- EPS
- +22.5%
- Free cash flow
- +1.99%
- Total debt
- +1.75%
Quarter to September 2026, against a year earlier
Follow AZN
Alert me
AstraZeneca PLC (AZN) Gross margin
AstraZeneca PLC's gross margin over the twelve months to 30 September 2026 was 81.9%, up 0.0 percentage points from fiscal 2025 (81.9%). Over the past ten years it has ranged from 66.8% (fiscal 2021) to 82.1% (fiscal 2016); the current reading is higher than 82% of that period. That is above the Drug Manufacturers General industry median of 73.0% and above the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 81.9% | 0.78 |
| FY2024 | 81.1% | (0.83) |
| FY2023 | 82.0% | 9.89 |
| FY2022 | 72.1% | 5.30 |
| FY2021 | 66.8% | (13.33) |
| FY2020 | 80.1% | 0.27 |
| FY2019 | 79.8% | 2.16 |
| FY2018 | 77.7% | (3.12) |
| FY2017 | 80.8% | (1.28) |
| FY2016 | 82.1% | 0.86 |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 81.8% | (1.78) |
| Jun 2026 | 83.6% | 1.12 |
| Mar 2026 | 82.5% | 2.59 |
| Dec 2025 | 79.9% | (1.67) |
| 43 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| AZN AstraZeneca PLC | 81.9% |
| NVO Novo Nordisk A/S compare | 80.7% |
| GILD Gilead Sciences, Inc. compare | 79.9% |
| NVS Novartis AG compare | 74.9% |
| ABBV AbbVie Inc. compare | 73.7% |
| PFE Pfizer Inc. compare | 73.4% |
| MRK Merck & Co., Inc. compare | 71.8% |
| AMGN Amgen Inc. compare | 70.9% |
| BMY Bristol Myers Squibb Company compare | 69.2% |
| Drug Manufacturers General industry median | 73.0% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on AZN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement